Uterine cervical neoplasms Clinical Trials
Conditions / Uterine cervical neoplasms
Delta Trials catalogs 129 clinical trials for Uterine cervical neoplasms in its publicly accessible dataset. Within this set, 22 currently recruiting participants and 52 trials have reached completion. This research occurs across 518 participating sites around the world. An additional 55 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 11 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
129
Total Trials
22
Recruiting
52
Completed
55
Other Active
11
Terminated since 2020
518
Study Locations
Browse by location (518 total)
- Beijing, China 11 trialsAll trials in Beijing, China
- Seoul, South Korea 9 trialsAll trials in Seoul, South Korea
- Toronto, Canada 8 trialsAll trials in Toronto, Canada
- Wuhan, China 8 trialsAll trials in Wuhan, China
- Milan, Italy 7 trialsAll trials in Milan, Italy
- Barcelona, Spain 7 trialsAll trials in Barcelona, Spain
- New York, United States 7 trialsAll trials in New York, United States
- Hangzhou, China 7 trialsAll trials in Hangzhou, China
- Guangzhou, China 7 trialsAll trials in Guangzhou, China
- St. Louis, United States 6 trialsAll trials in St. Louis, United States
- St. Louis, United States 6 trialsAll trials in St. Louis, United States
- Rome, Italy 6 trialsAll trials in Rome, Italy
- Madrid, Spain 6 trialsAll trials in Madrid, Spain
- Shanghai, China 6 trialsAll trials in Shanghai, China
- São Paulo, Brazil 5 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 5 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 5 trialsAll trials in São Paulo, Brazil
- São Paulo, Brazil 5 trialsAll trials in São Paulo, Brazil
- Taipei, Taiwan 5 trialsAll trials in Taipei, Taiwan
- São Paulo, Brazil 5 trialsAll trials in São Paulo, Brazil